Consumer genetics company 23andMe announced Friday it has signed a definitive agreement to acquire telehealth and online prescription platform Lemonaid Health for $400 million.
The price tag, subject to downward adjustments, will be made up of 25% in cash and 75% in stock. The companies expect the acquisition to close by the end of the year.
“We believe that by combining Lemonaid Health’s...
Lemonaid Health, a San Francisco-based telehealth platform and provider, announced today $33 million in Series B funding. The new round was led by Olive Tree Ventures, and included Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and other unnamed backers. This latest round brings the company's fundraising total to $55 million.
Lemonaid said it will be using the new funds to...
Scanwell Health, maker of a smartphone-based platform for home urinary tract infection screening, has raised $3.5 million in seed funding. Founders Fund, Mayfield, DCM, Version One, Y Combinator and Liquid 2 Ventures all participated in the round.
The startup paired this announcement with the reveal of a new partnership with telehealth service Lemonaid Health that will bring its UTI platform to...
San Francisco-based Lemonaid Health, which offers a simple, text-based telemedicine app, has raised $11 million in Series A funding. Novartis Venture Fund and Hikma Ventures led the round, with participation from Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures. The company last received funding in 2015, and the latest investment brings Lemonaid’s total capital to...
